Integrating pulmonary function testing with cardiopulmonary exercise testing for enhanced stratification in...

Area of Science:

• Cardiology
• Pulmonology
• Exercise Physiology

Background:

• Cardiopulmonary exercise testing (CPET) is crucial for evaluating hypertrophic cardiomyopathy (HCM) patients.
• The utility of pulmonary function testing (PFT) in stratifying HCM patients is not well understood.

Purpose of the Study:

• To investigate the relationship between PFT and CPET parameters in individuals with HCM.
• To determine if PFT can refine patient stratification in HCM.

Main Methods:

• A prospective, two-center study involving 102 stable HCM patients.
• Utilized Spearman's correlation and multiple linear regression to analyze PFT (FVC, FEV1) and CPET variables.
• Adjusted for potential confounding factors in the analysis.

Main Results:

• HCM patients demonstrated preserved lung function (mean FVC: 90.7%, FEV1: 92.5%).
• Significant correlations were found between PFT metrics and CPET variables, including peak oxygen consumption (VO2) and peak ventilation.
• Regression analysis confirmed independent associations between PFT and CPET performance (p<0.001).

Conclusions:

• Pulmonary function testing metrics show a strong correlation with CPET parameters in HCM.
• PFT may serve as a valuable adjunct to CPET for a more thorough assessment of exercise capacity.
• PFT could improve patient stratification in hypertrophic cardiomyopathy.